Blog

Theravance Biopharma (TBPH) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss of $0.05 per share a year ago. These

General Mills, Inc. GIS continues to actively reshape the business portfolio as part of its long-term growth strategy. In line with this effort, the company recently announced a move to streamline

For Immediate Release

Chicago, IL – March 19, 2026 – Today, Zacks Equity Research discusses Equity Residential EQR and Equity LifeStyle Properties ELS.

Industry: Residential REIT

Link: https://www.z

Investors in Bar Harbor Bankshares BHB need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2026 $15.00 Call had some of the highest

Wall Street has been hit by turbulence. Rising inflation has once again raised concerns about an economic slowdown, as the Federal Reserve left interest rates unchanged on Wednesday. Also

Bank of America’s BAC push to embed artificial intelligence (AI) and digital tools deeper into its franchise is emerging as a meaningful revenue-growth lever, not just an efficiency story. Last

ResMed (RMD) has been on a downward spiral lately with significant selling pressure. After declining 12% over the past four weeks, the stock looks well positioned for a trend reversal as it is now

A downtrend has been apparent in Toyota Motor Corporation (TM) lately with too much selling pressure. The stock has declined 14% over the past four weeks. However, given the fact that it is now in

Octave Specialty Group (OSG) has been on a downward spiral lately with significant selling pressure. After declining 15.5% over the past four weeks, the stock looks well positioned for a trend

Sprout Social (SPT) has been on a downward spiral lately with significant selling pressure. After declining 22% over the past four weeks, the stock looks well positioned for a trend reversal as it

Hancock Whitney (HWC) has been on a downward spiral lately with significant selling pressure. After declining 13.9% over the past four weeks, the stock looks well positioned for a trend reversal as

Five Below, Inc. FIVE reported impressive fourth-quarter fiscal 2025 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Also, net sales and earnings increased year over

For Immediate Release

Chicago, IL – March 19, 2026 – Today, Zacks Equity Research discusses Morgan Stanley MS, Interactive Brokers Group, Inc. IBKR and Evercore Inc. EVR.

Industry: Investment

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Accenture (ACN) reported $18.04 billion in revenue for the quarter ended February 2026, representing a year-over-year increase of 8.3%. EPS of $2.93 for the same period compares to $2.82 a year ago.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

For the quarter ended December 2025, Aveanna Healthcare (AVAH) reported revenue of $662.48 million, up 27.4% over the same period last year. EPS came in at $0.17, compared to $0.05 in the year-ago

For the quarter ended January 2026, Titan Machinery (TITN) reported revenue of $641.83 million, down 15.5% over the same period last year. EPS came in at -$1.43, compared to -$1.98 in the year-ago

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts